Bills · HR 4392
IN COMMITTEE· 119TH CONGRESS
House BillHR 4392Health
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
INTRO JUL 15· LAST ACTION JUL 15
READING
4MIN
COSPONSORS
54
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenUterine fibroids are a common health issue, affecting millions of women, often causing significant pain, heavy bleeding, and other symptoms that impact quality of life and can lead to serious health complications if not addressed. This bill matters because it seeks to tackle these challenges by boosting research into better ways to detect and treat fibroids early, which could prevent more severe symptoms and the need for more invasive procedures down the line.
If this bill becomes law, there would be more federal focus and funding to address uterine fibroids, potentially leading to new detection methods, improved treatment strategies, and increased public awareness. This could mean fewer women suffering undiagnosed or undertreated fibroids, especially in communities that currently face barriers to care. Without this bill, current efforts to understand and treat uterine fibroids might remain fragmented and underfunded, leaving many women without access to the best available care or information.
KEY PROVISIONS
4AI-extractedPROVISION 01
The Secretary of Health and Human Services (HHS) must conduct or support research to improve early detection and intervention for uterine fibroids.
This provision aims to advance medical knowledge and create better diagnostic and treatment strategies for uterine fibroids.
PROVISION 02
HHS may award grants to states to create programs for increasing early detection and intervention, as well as developing public awareness campaigns about uterine fibroids.
This allows states to implement practical, community-level initiatives to reach more people and educate them about uterine fibroids.
PROVISION 03
In awarding grants, HHS must give priority to states that propose programs for socially vulnerable populations at higher risk of uterine fibroids.
This ensures that resources are directed to communities that often face greater health disparities and may have less access to care.
PROVISION 04
HHS may also award grants for research, including clinical trials, on disparities in pain control during fibroid surgery and other intrauterine conditions.
This provision addresses specific gaps in knowledge and care related to pain management and other gynecological issues often associated with fibroids.
SPONSORSHIP
1 + 54
D· Ohio
YRS IN OFFICE
4
BILLS LED
26
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 54 REP 0 IND 0
ACTION TIMELINE
2 EVENTSJUL 15
Introduced in House
JUL 15
Referred to the House Committee on Energy and Commerce.
BILL INFO
TypeHouse Bill
NumberHR 4392
Congress119th
StatusIn Committee
IntroducedJul 15, 2025
Last actionJul 15, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ENERGY AND COMMERCE COMMITTEE · INTRODUCED JUL 15, 2025
House BillHR 4392Health
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
INTRODUCED JUL 15, 2025· LAST ACTION JUL 15, 2025
PASSAGE CHANCES
—%
READING
4 min
COSPONSORS
54
COMPLEXITY
Moderate
